ID: ALA421173

Max Phase: Preclinical

Molecular Formula: C11H11NO5

Molecular Weight: 237.21

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O)C(=O)NC(Cc1ccccc1)C(=O)O

Standard InChI:  InChI=1S/C11H11NO5/c13-9(11(16)17)12-8(10(14)15)6-7-4-2-1-3-5-7/h1-5,8H,6H2,(H,12,13)(H,14,15)(H,16,17)

Standard InChI Key:  ULQWGBCNOHBNDB-UHFFFAOYSA-N

Associated Targets(non-human)

P4ha1 Prolyl 4-hydroxylase alpha-1 subunit (36 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 237.21Molecular Weight (Monoisotopic): 237.0637AlogP: -0.12#Rotatable Bonds: 4
Polar Surface Area: 103.70Molecular Species: ACIDHBA: 3HBD: 3
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 2.78CX Basic pKa: CX LogP: 0.86CX LogD: -5.93
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.63Np Likeness Score: 0.03

References

1. Cunliffe CJ, Franklin TJ, Hales NJ, Hill GB..  (1992)  Novel inhibitors of prolyl 4-hydroxylase. 3. Inhibition by the substrate analogue N-oxaloglycine and its derivatives.,  35  (14): [PMID:1321909] [10.1021/jm00092a016]

Source